Adaptive immune contexture at the tumour site and downmodulation of circulating myeloid-derived suppressor cells in the response of solitary fibrous tumour patients to anti-angiogenic therapy

BACKGROUND: Host immunity is emerging as a key player in the prognosis and response to treatment of cancer patients. However, the impact of the immune system and its modulation by therapies are unknown in rare soft tissue sarcomas such as solitary fibrous tumours (SFTs), whose management in the adva...

Descripción completa

Detalles Bibliográficos
Autores principales: Tazzari, M, Negri, T, Rini, F, Vergani, B, Huber, V, Villa, A, Dagrada, P, Colombo, C, Fiore, M, Gronchi, A, Stacchiotti, S, Casali, P G, Pilotti, S, Rivoltini, L, Castelli, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183857/
https://www.ncbi.nlm.nih.gov/pubmed/25101565
http://dx.doi.org/10.1038/bjc.2014.437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183857/
https://www.ncbi.nlm.nih.gov/pubmed/25101565
http://dx.doi.org/10.1038/bjc.2014.437

Ejemplares similares